A citation-based method for searching scientific literature

Konstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, Asterios Karagiannis, Vasilios G Athyros. Expert Rev Clin Pharmacol 2017
Times Cited: 7







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
57

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
42

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.
H J Lambers Heerspink, D de Zeeuw, L Wie, B Leslie, J List. Diabetes Obes Metab 2013
416
42

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
28


Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes.
Li Tang, Yuanyuan Wu, Mi Tian, C David Sjöström, Ulrika Johansson, Xiao-Rong Peng, David M Smith, Yufeng Huang. Am J Physiol Endocrinol Metab 2017
46
28

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Liang Xu, Naoto Nagata, Mayumi Nagashimada, Fen Zhuge, Yinhua Ni, Guanliang Chen, Eric Mayoux, Shuichi Kaneko, Tsuguhito Ota. EBioMedicine 2017
130
28

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
437
28

Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
Norihisa Nishimura, Mitsuteru Kitade, Ryuichi Noguchi, Tadashi Namisaki, Kei Moriya, Kosuke Takeda, Yasushi Okura, Yosuke Aihara, Akitoshi Douhara, Hideto Kawaratani,[...]. J Gastroenterol 2016
27
28

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
Yasushi Honda, Kento Imajo, Takayuki Kato, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Hironori Mawatari, Koji Fujita, Masato Yoneda,[...]. PLoS One 2016
97
28

Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Naoto Terami, Daisuke Ogawa, Hiromi Tachibana, Takashi Hatanaka, Jun Wada, Atsuko Nakatsuka, Jun Eguchi, Chikage Sato Horiguchi, Naoko Nishii, Hiroshi Yamada,[...]. PLoS One 2014
166
28

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Volker Vallon, Michael Rose, Maria Gerasimova, Joseph Satriano, Kenneth A Platt, Hermann Koepsell, Robyn Cunard, Kumar Sharma, Scott C Thomson, Timo Rieg. Am J Physiol Renal Physiol 2013
212
28

The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
Dong Wang, Yuhuan Luo, Xiaoxin Wang, David J Orlicky, Komuraiah Myakala, Pengyuan Yang, Moshe Levi. Int J Mol Sci 2018
29
28

Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats.
Nuttawud Chueakula, Krit Jaikumkao, Phatchawan Arjinajarn, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Nipon Chattipakorn, Anusorn Lungkaphin. Free Radic Biol Med 2018
19
28

Prebiotic prevents impaired kidney and renal Oat3 functions in obese rats.
Keerati Wanchai, Sakawdaurn Yasom, Wannipa Tunapong, Titikorn Chunchai, Parameth Thiennimitr, Chaiyavat Chaiyasut, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn Chattipakorn, Nipon Chattipakorn,[...]. J Endocrinol 2018
13
28



SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.
Konstantinos Imprialos, Charles Faselis, Chrysoula Boutari, Konstantinos Stavropoulos, Vasilios Athyros, Asterios Karagiannis, Michael Doumas. Curr Pharm Des 2017
10
28

Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?
Konstantinos P Imprialos, Pantelis A Sarafidis, Asterios I Karagiannis. J Hypertens 2015
43
28

Cardiac Autonomic Function Is Associated With the Coronary Microcirculatory Function in Patients With Type 2 Diabetes.
Bernt Johan von Scholten, Christian Stevns Hansen, Philip Hasbak, Andreas Kjaer, Peter Rossing, Tine Willum Hansen. Diabetes 2016
11
14

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, Sophia Zoungas, Avinesh Pillai, Meg Jardine, Anushka Patel, Alan Cass, Bruce Neal, Neil Poulter,[...]. J Am Soc Nephrol 2009
569
14

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
Honghong Zou, Baoqin Zhou, Gaosi Xu. Cardiovasc Diabetol 2017
37
14

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
14

Albuminuria reflects widespread vascular damage. The Steno hypothesis.
T Deckert, B Feldt-Rasmussen, K Borch-Johnsen, T Jensen, A Kofoed-Enevoldsen. Diabetologia 1989
14

Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs.
Vincent Dunet, Ran Klein, Gilles Allenbach, Jennifer Renaud, Robert A deKemp, John O Prior. J Nucl Cardiol 2016
20
14

Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition.
Birger Hesse, Christian Meyer, Flemming S Nielsen, Asako Sato, Jens D Hove, Soeren Holm, Lia E Bang, Klaus F Kofoed, Tage L Svendsen, Hans-Henrik Parving,[...]. Eur J Nucl Med Mol Imaging 2004
14
14


Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Auni Juutilainen, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälä, Markku Laakso. Diabetes Care 2007
135
14

Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
Venkatesh L Murthy, Masanao Naya, Courtney R Foster, Jon Hainer, Mariya Gaber, Gilda Di Carli, Ron Blankstein, Sharmila Dorbala, Arkadiusz Sitek, Michael J Pencina,[...]. Circulation 2011
465
14

Blood pressure control in type 2 diabetic patients.
Alon Grossman, Ehud Grossman. Cardiovasc Diabetol 2017
29
14

Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET/CT and SPECT/CT with standard Agatston score.
Andrew J Einstein, Lynne L Johnson, Sabahat Bokhari, Jessica Son, Randall C Thompson, Timothy M Bateman, Sean W Hayes, Daniel S Berman. J Am Coll Cardiol 2010
114
14


Relationship between glycosylated hemoglobin A1c and coronary flow reserve in patients with Type 2 diabetes mellitus.
Runqing Huang, Sahar S Abdelmoneim, Lara F Nhola, Rita Basu, Ananda Basu, Sharon L Mulvagh. Expert Rev Cardiovasc Ther 2015
7
14

Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
Takayuki Kawata, Masao Daimon, Sakiko Miyazaki, Ryoko Ichikawa, Masaki Maruyama, Shuo-Ju Chiang, Chiharu Ito, Fumihiko Sato, Hirotaka Watada, Hiroyuki Daida. Cardiovasc Diabetol 2015
32
14

Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus.
T Akasaka, K Yoshida, T Hozumi, T Takagi, S Kaji, T Kawamoto, S Morioka, J Yoshikawa. J Am Coll Cardiol 1997
94
14

Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.
I Yokoyama, S Momomura, T Ohtake, K Yonekura, J Nishikawa, Y Sasaki, M Omata. J Am Coll Cardiol 1997
187
14

Increased frequency of chromosome congression defects and aneuploidy in mouse oocytes cultured at lower temperature.
Jitka Danadova, Natalie Matijescukova, Anna Mac Gillavry Danylevska, Martin Anger. Reprod Fertil Dev 2017
4
25

Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction.
J Czernin, G Porenta, R Brunken, J Krivokapich, K Chen, R Bennett, A Hage, C Fung, J Tillisch, M E Phelps. Circulation 1993
85
14

Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
J Sundell, T Janatuinen, T Rönnemaa, O T Raitakari, J Toikka, P Nuutila, J Knuuti. Diabetologia 2004
17
14

Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
Maria C Ziadi, Robert A Dekemp, Kathryn A Williams, Ann Guo, Benjamin J W Chow, Jennifer M Renaud, Terrence D Ruddy, Niroshi Sarveswaran, Rebecca E Tee, Rob S B Beanlands. J Am Coll Cardiol 2011
338
14

Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
Marcelo F Di Carli, James Janisse, George Grunberger, Joel Ager. J Am Coll Cardiol 2003
262
14

Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries.
Emmanuel Cosson, Isabelle Pham, Paul Valensi, Jacques Pariès, Jean-Raymond Attali, Alain Nitenberg. Diabetes Care 2006
55
14

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Alan S Go, Glenn M Chertow, Dongjie Fan, Charles E McCulloch, Chi-yuan Hsu. N Engl J Med 2004
14

Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.
Rajesh Garg, Ajay D Rao, Maria Baimas-George, Shelley Hurwitz, Courtney Foster, Ravi V Shah, Michael Jerosch-Herold, Raymond Y Kwong, Marcelo F Di Carli, Gail K Adler. Diabetes 2015
78
14

Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.
Bernhard A Herzog, Lars Husmann, Ines Valenta, Oliver Gaemperli, Patrick T Siegrist, Fabian M Tay, Nina Burkhard, Christophe A Wyss, Philipp A Kaufmann. J Am Coll Cardiol 2009
405
14

Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients.
Andreas Kjaer, Ulrik Sloth Kristoffersen, Lise Tarnow, Hans-Henrik Parving, Birger Hesse. Diabetes Res Clin Pract 2009
6
16

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner,[...]. Lancet Diabetes Endocrinol 2015
309
14

Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus.
Venkatesh L Murthy, Masanao Naya, Courtney R Foster, Mariya Gaber, Jon Hainer, Josh Klein, Sharmila Dorbala, Ron Blankstein, Marcelo F Di Carli. Circulation 2012
273
14

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.
Christian Ott, Agnes Jumar, Kristina Striepe, Stefanie Friedrich, Marina V Karg, Peter Bramlage, Roland E Schmieder. Cardiovasc Diabetol 2017
67
14

Changes in diabetes-related complications in the United States.
Edward W Gregg, Desmond E Williams, Linda Geiss. N Engl J Med 2014
36
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.